FDA Drug recall D-0018-2015
Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at Valeant Pharmaceutica…
- FDA Drug
- Class III
- terminated
- Published 2014-10-22
On 2014-10-22 the FDA classified a Class III recall of Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at Valeant Pharmaceutica… by Valeant Pharmaceuticals North America, citing labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0018-2015 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-05-21 |
| Published | 2014-10-22 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Valeant Pharmaceuticals North America |
| Distribution | US |
Product
Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada
Reason
Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset
Identifiers
| ndc | 0187-0146-01 |
|---|---|
| code_info | VASERETIC 10-25MG TAB 100CT Lot # 12J022P exp. 9/30/2014 VASERETIC 10-25MG TAB 100CT Lot # 13G047P exp. 07/31/2015 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0018-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.